rs2271441

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003282.4(TNNI2):​c.186+26G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 1,612,006 control chromosomes in the GnomAD database, including 34,991 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2701 hom., cov: 34)
Exomes 𝑓: 0.20 ( 32290 hom. )

Consequence

TNNI2
NM_003282.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 0.180

Publications

7 publications found
Variant links:
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
TNNI2 Gene-Disease associations (from GenCC):
  • distal arthrogryposis type 2B1
    Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-1840682-G-A is Benign according to our data. Variant chr11-1840682-G-A is described in ClinVar as Benign. ClinVar VariationId is 140483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNI2NM_003282.4 linkc.186+26G>A intron_variant Intron 5 of 7 ENST00000381911.6 NP_003273.1 P48788-1
TNNI2NM_001145829.2 linkc.186+26G>A intron_variant Intron 5 of 7 NP_001139301.1 P48788-1
TNNI2NM_001145841.2 linkc.186+26G>A intron_variant Intron 3 of 5 NP_001139313.1 P48788-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNI2ENST00000381911.6 linkc.186+26G>A intron_variant Intron 5 of 7 2 NM_003282.4 ENSP00000371336.1 P48788-1

Frequencies

GnomAD3 genomes
AF:
0.175
AC:
26637
AN:
151970
Hom.:
2700
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.101
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.345
Gnomad EAS
AF:
0.0535
Gnomad SAS
AF:
0.189
Gnomad FIN
AF:
0.171
Gnomad MID
AF:
0.279
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.183
AC:
44897
AN:
245690
AF XY:
0.189
show subpopulations
Gnomad AFR exome
AF:
0.0931
Gnomad AMR exome
AF:
0.113
Gnomad ASJ exome
AF:
0.344
Gnomad EAS exome
AF:
0.0541
Gnomad FIN exome
AF:
0.168
Gnomad NFE exome
AF:
0.222
Gnomad OTH exome
AF:
0.217
GnomAD4 exome
AF:
0.204
AC:
298500
AN:
1459918
Hom.:
32290
Cov.:
44
AF XY:
0.206
AC XY:
149755
AN XY:
726252
show subpopulations
African (AFR)
AF:
0.0921
AC:
3084
AN:
33470
American (AMR)
AF:
0.118
AC:
5284
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.341
AC:
8902
AN:
26122
East Asian (EAS)
AF:
0.0643
AC:
2552
AN:
39660
South Asian (SAS)
AF:
0.195
AC:
16823
AN:
86226
European-Finnish (FIN)
AF:
0.168
AC:
8782
AN:
52126
Middle Eastern (MID)
AF:
0.283
AC:
1609
AN:
5694
European-Non Finnish (NFE)
AF:
0.215
AC:
239142
AN:
1111598
Other (OTH)
AF:
0.204
AC:
12322
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
14127
28254
42380
56507
70634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8060
16120
24180
32240
40300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.175
AC:
26646
AN:
152088
Hom.:
2701
Cov.:
34
AF XY:
0.172
AC XY:
12813
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.102
AC:
4215
AN:
41512
American (AMR)
AF:
0.161
AC:
2466
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.345
AC:
1199
AN:
3472
East Asian (EAS)
AF:
0.0540
AC:
278
AN:
5148
South Asian (SAS)
AF:
0.190
AC:
914
AN:
4808
European-Finnish (FIN)
AF:
0.171
AC:
1816
AN:
10598
Middle Eastern (MID)
AF:
0.262
AC:
76
AN:
290
European-Non Finnish (NFE)
AF:
0.222
AC:
15058
AN:
67944
Other (OTH)
AF:
0.207
AC:
437
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1133
2266
3400
4533
5666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.218
Hom.:
725
Bravo
AF:
0.169
Asia WGS
AF:
0.108
AC:
376
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
TNNI2 homepage - Leiden Muscular Dystrophy pages
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Distal arthrogryposis type 2B1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
6.0
DANN
Benign
0.84
PhyloP100
0.18
PromoterAI
0.030
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2271441; hg19: chr11-1861912; COSMIC: COSV53290331; COSMIC: COSV53290331; API